Faq

The safety of a peptide relies on various factors, such as the specific compound, dosage, purity, and individual health conditions. While some peptides are well-researched for human use, others are not, and ‘Research Use Only’ peptides typically lack comprehensive safety data.

Peptides are short strings of amino acids that naturally exist in the body, playing vital roles in many functions including signaling, metabolism, and immune responses.

No, peptides and anabolic steroids are different. Peptides act as signaling molecules, while anabolic steroids are synthetic forms of testosterone.

‘Research Use Only’ indicates that a product is meant for lab research and isn’t approved for human consumption or medical use.

Yes, some peptides are FDA-approved for specific medical conditions, but many available online have not undergone such approval and aren’t endorsed for human use.

These terms describe how many metabolic hormone receptors a peptide activates simultaneously. GLP-1 agonist (e.g., Semaglutide): activates one receptor, GLP-1R, which reduces appetite and slows gastric emptying. Dual agonist (e.g., Tirzepatide): activates two, GLP-1R and GIPR, providing additive metabolic signaling through complementary pathways. Triple agonist (e.g., Retatrutide): activates three, GLP-1R, GIPR, and GLP-2R, offering the broadest receptor coverage studied in this class to date. Each additional receptor engagement adds a distinct physiological signal, which is why research has generally shown increased metabolic effect as the number of pathways increases. All are studied under strict research protocols.

DAC stands for “Drug Affinity Complex” — a chemical modification that covalently binds the peptide to albumin in the bloodstream, dramatically extending its half-life from ~30 minutes (no DAC) to approximately 8 days (with DAC). The two forms have meaningfully different research profiles.

CJC-1295 No DAC (also called Modified GRF 1-29): Short-acting, produces pulsatile GH release. Typically combined with a GHRP and dosed 1–2x daily around meals.

CJC-1295 with DAC: Long-acting, sustains elevated GH levels. Dosed once or twice weekly; the sustained GH elevation may blunt the natural pulsatile rhythm.

For protocols prioritizing physiologically patterned GH release, the No DAC form is generally preferred in research design.

These two classes work through entirely different receptors and are frequently studied in combination because they are synergistic.

GHRH Analogues — stimulate the GHRH receptor on the pituitary (examples: Sermorelin, CJC-1295, Tesamorelin) — trigger GH release in physiological pulses.

GHRPs — stimulate the ghrelin receptor on the pituitary (examples: Ipamorelin, GHRP-2, GHRP-6) — amplify the GH pulse and block somatostatin.

When used together (e.g., CJC-1295 + Ipamorelin), the dual-receptor stimulation produces significantly greater GH release than either compound alone — which is why combination blends like CJI-10 are widely used in research protocols.

MOTS-C is unique because it is not encoded in nuclear DNA like most peptides — it is encoded within mitochondrial DNA (mtDNA), specifically in the 12S rRNA region. This makes it a “mitochondria-derived peptide” (MDP). After translation inside mitochondria, MOTS-C is released into the cytoplasm and nucleus, where it activates AMPK (AMP-activated protein kinase) — a central regulator of cellular energy metabolism. Research has shown MOTS-C to improve insulin sensitivity, regulate fat metabolism, and extend lifespan in animal models. Circulating levels of MOTS-C decline with age, which has generated significant interest in the longevity research community.

Both were developed at the Institute of Molecular Genetics in Moscow and are among the most studied nootropic peptides, but they have distinct mechanisms and applications.

Selank — base peptide: Tuftsin analogue. Primary effect: anxiolytic, anti-stress. Key mechanism: GABA modulation, anxiolysis. Research use: anxiety, stress, immune support. Administration: SubQ or intranasal.

Semax — base peptide: ACTH(4-7) analogue. Primary effect: cognitive enhancement, focus. Key mechanism: BDNF upregulation, dopamine. Research use: cognition, stroke recovery, mood. Administration: primarily intranasal.

Some research protocols use both together — Selank for the anxiety/stress component and Semax for cognitive performance enhancement.

Both are alpha-MSH analogues that stimulate melanin production, but their receptor selectivity creates significant differences in their research profiles.

Melanotan I (MT-I) — receptor targets: MC1R only. Pigmentation: strong, selective. Central effects: minimal. Nausea/flushing risk: lower.

Melanotan II (MT-II) — receptor targets: MC1R, MC3R, MC4R, MC5R. Pigmentation: strong. Central effects: significant (libido, appetite). Nausea/flushing risk: higher (especially at higher doses).

Melanotan I’s MC1R selectivity makes it the more targeted option purely for pigmentation and photoprotection research. Melanotan II’s broader receptor activity makes it relevant to studies involving melanocortin-mediated arousal and appetite — but also means more dose-sensitive side effects that require conservative research protocols.

Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide derived from epithalamin, a pineal gland extract. Research by Vladimir Khavinson demonstrated that Epitalon can activate telomerase — the enzyme that maintains telomere length — and modulate melatonin secretion and antioxidant defense. It is among the few compounds with peer-reviewed human longevity research demonstrating reduced mortality in treated groups vs. controls. Cyclical protocols (10–20 days on, 4–6 months off) are used because: (1) the research literature followed this framework; (2) telomere and neuroendocrine effects appear to persist well beyond the administration window; and (3) continuous administration has not been studied for long-term safety.

5-Amino-1MQ is an NNMT (Nicotinamide N-methyltransferase) inhibitor. NNMT is an enzyme that consumes NAD+ precursors (specifically SAM) by converting nicotinamide into methyl-nicotinamide — essentially depleting the building blocks needed for NAD+ production. By blocking NNMT, 5-Amino-1MQ preserves and elevates available NAD+ in tissues. Research shows this leads to increased SIRT1 activity, reduced fat cell formation (adipogenesis), and improved metabolic efficiency. The practical research implication: 5-Amino-1MQ and NAD+ supplementation can work synergistically — NAD+ replenishes the pool while 5-Amino-1MQ reduces its consumption.

Both peptides can be described as immune-supportive, but they operate through fundamentally different mechanisms and are not interchangeable.

Thymosin Alpha-1 — origin: thymus gland peptide. Primary mechanism: T-cell maturation, dendritic cells. Research focus: infections, immunity, cancer adjunct. Regulatory status: approved in multiple countries (Zadaxin).

BPC-157 — origin: gastric juice-derived peptide. Primary mechanism: gut repair, angiogenesis, nitric oxide. Research focus: GI healing, tendon repair, inflammation. Regulatory status: research compound only.

Thymosin Alpha-1 is specifically thymic — it directly supports the adaptive immune system’s cellular branch. BPC-157’s immune-adjacent effects come largely through gut healing, reduced systemic inflammation, and vascular repair rather than direct lymphocyte modulation.

Yes — blends and individual SKUs are not mutually exclusive. A common research design might use a blend as the foundation and add individual peptides to address specific objectives. For example:

GLOW + standalone TB-500: If a protocol requires the full GLOW matrix but also needs higher TB-500 dosing for acute musculoskeletal applications.

Wolverine + standalone BPC-157: Adding individual BPC-157 to increase the BPC-157 component while keeping the TB-500 ratio fixed.

KLOW + standalone KPV: For protocols targeting more aggressive gut inflammation that require higher KPV doses than the blend provides.

When stacking blends with their individual components, account for the contribution of each component in the blend to avoid unintentional over-dosing of any single peptide. Use the Reconstitution Calculator on this site to track each component’s dose across all sources.